QXO Inc (NYSE:QXO) Drops -83.38% In 2025; Is It Affordable At $16.27?

In last trading session, QXO Inc (NYSE:QXO) saw 2.62 million shares changing hands with its beta currently measuring 2.35. Company’s recent per share price level of $16.27 trading at $0.23 or 1.43% at ring of the bell on the day assigns it a market valuation of $8.44B. That closing price of QXO’s stock is at a discount of -1682.42% from its 52-week high price of $290.00 and is indicating a premium of 34.79% from its 52-week low price of $10.61.

QXO Inc (NYSE:QXO) trade information

Upright in the green during last session for gaining 1.43%, in the last five days QXO remained trading in the green while hitting it’s week-highest on Thursday, 05/15/25 when the stock touched $16.27 price level, adding 0.18% to its value on the day. QXO Inc’s shares saw a change of 2.33% in year-to-date performance and have moved 17.13% in past 5-day. QXO Inc (NYSE:QXO) showed a performance of 12.05% in past 30-days.

QXO Inc (QXO) estimates and forecasts

This year revenue growth is estimated to rise 4,392.47% from the last financial year’s standing.

1 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of 13M for the same. And 1 analysts are in estimates of company making revenue of 14M in the next quarter.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 55.18% during past 5 years.

QXO Inc (NYSE:QXO)’s Major holders

CITADEL ADVISORS LLC is the top institutional holder at QXO for having 9.3 million shares of worth $85.09 million. And as of 2024-06-30, it was holding 2.5922 of the company’s outstanding shares.

The second largest institutional holder is DRIEHAUS CAPITAL MANAGEMENT LLC, which was holding about 2.24 million shares on 2024-06-30. The number of shares represents firm’s hold over 0.6247 of outstanding shares, having a total worth of $20.49 million.

On the other hand, Advisor Managed Portfolios-Patient Opportunity Trust and T. Rowe Price Small-Cap Stock Fund, Inc. are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025, the former fund manager was holding 5.6 shares of worth $91.11 million or 1.25% of the total outstanding shares. The later fund manager was in possession of 4.82 shares on Dec 31, 2024, making its stake of worth around $78.46 million in the company or a holder of 1.08% of company’s stock.